Dr. Weinblatt is a board-certified Rheumatologist at Brigham & Women’s Hospital in Boston, MA and has almost 50 years of experience.

Dr. Weinblatt was the President of the American College of Rheumatology in 2001. Dr. Weinblatt is the author of The Arthritis Action Program: An Integrated Plan of Traditional and Complementary Therapies. He has also authored or co-authored more than 300 published papers, reviews, and book chapters on rheumatology. Additionally, he is the co-editor of Targeted Treatment of the Rheumatic Diseases and the textbook Rheumatology (3rd-8th editions).

His major research interest is in the therapeutics for rheumatoid arthritis, which includes studies of methotrexate and biologic response modifers. His work on the development of methotrexate therapy for rheumatoid arthritis garnered him the Carol Nachman Prize for Rheumatology and the Arthritis Foundation’s Virginia P. Engalitcheff Award for Impact on Quality of Life. In 2008, Dr. Weinblatt received the American College of Rheumatology Distinguished Clinical Investigator Award and the ACR Presidential Gold Medal in 2016.

Dr. Weinblatt earned a medical degree at the University of Maryland School of Medicine in Baltimore, where he also completed his internship and residency. He completed a clinical fellowship in rheumatology at the Robert B. Brigham Hospital, Harvard Medical School. He is the John R and Eileen K Riedman Professor of Medicine at Harvard Medical School and R. Bruce and Joan M. Mickey Distinguished Chair in Rheumatology, Division of Rheumatology, Inflammation and Immunity at Brigham & Women’s.